Muscarinic acetylcholine receptor M1 and M3 subtypes mediate acetylcholine-induced endothelium-independent vasodilatation in rat mesenteric arteries

Panot Tangsucharit, Shingo Takatori, Yoshito Zamami, Mitsuhiro Goda, Poungrat Pakdeechote, Hiromu Kawasaki, Fusako Takayama

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The present study investigated pharmacological characterizations of muscarinic acetylcholine receptor (AChR) subtypes involving ACh-induced endothelium-independent vasodilatation in rat mesenteric arteries. Changes in perfusion pressure to periarterial nerve stimulation and ACh were measured before and after the perfusion of Krebs solution containing muscarinic receptor antagonists. Distributions of muscarinic AChR subtypes in mesenteric arteries with an intact endothelium were studied using Western blotting. The expression level of M1 and M3 was significantly greater than that of M2. Endothelium removal significantly decreased expression levels of M2 and M3, but not M1. In perfused mesenteric vascular beds with intact endothelium and active tone, exogenous ACh (1, 10, and 100 nmol) produced concentration-dependent and long-lasting vasodilatations. In endothelium-denuded preparations, relaxation to ACh (1 nmol) disappeared, but ACh at 10 and 100 nmol caused long-lasting vasodilatations, which were markedly blocked by the treatment of pirenzepine (M1 antagonist) or 4-DAMP (M1 and M3 antagonist) plus hexamethonium (nicotinic AChR antagonist), but not methoctramine (M2 and M4 antagonist). These results suggest that muscarinic AChR subtypes, mainly M1, distribute throughout the rat mesenteric arteries, and that activation of M1 and/or M3 which may be located on CGRPergic nerves releases CGRP, causing an endothelium-independent vasodilatation.

Original languageEnglish
Pages (from-to)24-32
Number of pages9
JournalJournal of Pharmacological Sciences
Volume130
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Muscarinic M3 Receptors
Muscarinic M1 Receptors
Mesenteric Arteries
Muscarinic Receptors
Vasodilation
Acetylcholine
Endothelium
Perfusion
Pirenzepine
Hexamethonium
Muscarinic Antagonists
Nicotinic Receptors
Cholinergic Antagonists
Blood Vessels
Western Blotting
Pharmacology
Pressure

Keywords

  • Acetylcholine-induced vasodilatation
  • CGRPergic nerves
  • Muscarinic receptor subtypes
  • Rat mesenteric arteries

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Muscarinic acetylcholine receptor M1 and M3 subtypes mediate acetylcholine-induced endothelium-independent vasodilatation in rat mesenteric arteries. / Tangsucharit, Panot; Takatori, Shingo; Zamami, Yoshito; Goda, Mitsuhiro; Pakdeechote, Poungrat; Kawasaki, Hiromu; Takayama, Fusako.

In: Journal of Pharmacological Sciences, Vol. 130, No. 1, 01.01.2016, p. 24-32.

Research output: Contribution to journalArticle

Tangsucharit, Panot ; Takatori, Shingo ; Zamami, Yoshito ; Goda, Mitsuhiro ; Pakdeechote, Poungrat ; Kawasaki, Hiromu ; Takayama, Fusako. / Muscarinic acetylcholine receptor M1 and M3 subtypes mediate acetylcholine-induced endothelium-independent vasodilatation in rat mesenteric arteries. In: Journal of Pharmacological Sciences. 2016 ; Vol. 130, No. 1. pp. 24-32.
@article{87d6ba2cabdc4708b5b8be493827f870,
title = "Muscarinic acetylcholine receptor M1 and M3 subtypes mediate acetylcholine-induced endothelium-independent vasodilatation in rat mesenteric arteries",
abstract = "The present study investigated pharmacological characterizations of muscarinic acetylcholine receptor (AChR) subtypes involving ACh-induced endothelium-independent vasodilatation in rat mesenteric arteries. Changes in perfusion pressure to periarterial nerve stimulation and ACh were measured before and after the perfusion of Krebs solution containing muscarinic receptor antagonists. Distributions of muscarinic AChR subtypes in mesenteric arteries with an intact endothelium were studied using Western blotting. The expression level of M1 and M3 was significantly greater than that of M2. Endothelium removal significantly decreased expression levels of M2 and M3, but not M1. In perfused mesenteric vascular beds with intact endothelium and active tone, exogenous ACh (1, 10, and 100 nmol) produced concentration-dependent and long-lasting vasodilatations. In endothelium-denuded preparations, relaxation to ACh (1 nmol) disappeared, but ACh at 10 and 100 nmol caused long-lasting vasodilatations, which were markedly blocked by the treatment of pirenzepine (M1 antagonist) or 4-DAMP (M1 and M3 antagonist) plus hexamethonium (nicotinic AChR antagonist), but not methoctramine (M2 and M4 antagonist). These results suggest that muscarinic AChR subtypes, mainly M1, distribute throughout the rat mesenteric arteries, and that activation of M1 and/or M3 which may be located on CGRPergic nerves releases CGRP, causing an endothelium-independent vasodilatation.",
keywords = "Acetylcholine-induced vasodilatation, CGRPergic nerves, Muscarinic receptor subtypes, Rat mesenteric arteries",
author = "Panot Tangsucharit and Shingo Takatori and Yoshito Zamami and Mitsuhiro Goda and Poungrat Pakdeechote and Hiromu Kawasaki and Fusako Takayama",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.jphs.2015.12.005",
language = "English",
volume = "130",
pages = "24--32",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8648",
publisher = "The Japanese Pharmacological Society",
number = "1",

}

TY - JOUR

T1 - Muscarinic acetylcholine receptor M1 and M3 subtypes mediate acetylcholine-induced endothelium-independent vasodilatation in rat mesenteric arteries

AU - Tangsucharit, Panot

AU - Takatori, Shingo

AU - Zamami, Yoshito

AU - Goda, Mitsuhiro

AU - Pakdeechote, Poungrat

AU - Kawasaki, Hiromu

AU - Takayama, Fusako

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The present study investigated pharmacological characterizations of muscarinic acetylcholine receptor (AChR) subtypes involving ACh-induced endothelium-independent vasodilatation in rat mesenteric arteries. Changes in perfusion pressure to periarterial nerve stimulation and ACh were measured before and after the perfusion of Krebs solution containing muscarinic receptor antagonists. Distributions of muscarinic AChR subtypes in mesenteric arteries with an intact endothelium were studied using Western blotting. The expression level of M1 and M3 was significantly greater than that of M2. Endothelium removal significantly decreased expression levels of M2 and M3, but not M1. In perfused mesenteric vascular beds with intact endothelium and active tone, exogenous ACh (1, 10, and 100 nmol) produced concentration-dependent and long-lasting vasodilatations. In endothelium-denuded preparations, relaxation to ACh (1 nmol) disappeared, but ACh at 10 and 100 nmol caused long-lasting vasodilatations, which were markedly blocked by the treatment of pirenzepine (M1 antagonist) or 4-DAMP (M1 and M3 antagonist) plus hexamethonium (nicotinic AChR antagonist), but not methoctramine (M2 and M4 antagonist). These results suggest that muscarinic AChR subtypes, mainly M1, distribute throughout the rat mesenteric arteries, and that activation of M1 and/or M3 which may be located on CGRPergic nerves releases CGRP, causing an endothelium-independent vasodilatation.

AB - The present study investigated pharmacological characterizations of muscarinic acetylcholine receptor (AChR) subtypes involving ACh-induced endothelium-independent vasodilatation in rat mesenteric arteries. Changes in perfusion pressure to periarterial nerve stimulation and ACh were measured before and after the perfusion of Krebs solution containing muscarinic receptor antagonists. Distributions of muscarinic AChR subtypes in mesenteric arteries with an intact endothelium were studied using Western blotting. The expression level of M1 and M3 was significantly greater than that of M2. Endothelium removal significantly decreased expression levels of M2 and M3, but not M1. In perfused mesenteric vascular beds with intact endothelium and active tone, exogenous ACh (1, 10, and 100 nmol) produced concentration-dependent and long-lasting vasodilatations. In endothelium-denuded preparations, relaxation to ACh (1 nmol) disappeared, but ACh at 10 and 100 nmol caused long-lasting vasodilatations, which were markedly blocked by the treatment of pirenzepine (M1 antagonist) or 4-DAMP (M1 and M3 antagonist) plus hexamethonium (nicotinic AChR antagonist), but not methoctramine (M2 and M4 antagonist). These results suggest that muscarinic AChR subtypes, mainly M1, distribute throughout the rat mesenteric arteries, and that activation of M1 and/or M3 which may be located on CGRPergic nerves releases CGRP, causing an endothelium-independent vasodilatation.

KW - Acetylcholine-induced vasodilatation

KW - CGRPergic nerves

KW - Muscarinic receptor subtypes

KW - Rat mesenteric arteries

UR - http://www.scopus.com/inward/record.url?scp=84957546274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957546274&partnerID=8YFLogxK

U2 - 10.1016/j.jphs.2015.12.005

DO - 10.1016/j.jphs.2015.12.005

M3 - Article

C2 - 26825997

AN - SCOPUS:84957546274

VL - 130

SP - 24

EP - 32

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8648

IS - 1

ER -